Abstract. Male rats, body weight 60\p=n-\75 g, were hypophysectomized. Three days after operation the animals were divided into two groups. Group B received solvent solution and group C 1 mg/kg body weight per day of glibenclamide ip for the following 9 days. Group A consisted on non-operated normal rats. Twenty-four hours after the last injections and after a 12 h overnight fast the body weights of groups B and C were not different, the increase during the 10 days being 10% in both groups. Serum insulin (IRI) was significantly higher in group C than in group B (C: 8.0 \ m=+-\0.3 \g=m\U/ml, n = 14 vs B: 4.9 \m=+-\1.0 \g=m\U/ml,n = 14; P < 0.01, mean \m=+-\sem) as was serum somatomedin bioactivity (SM)-porcine cartilage assay\p=m-\(C: 1.06 \m=+-\ 0. 1U/ml, n = 14vsB:0.41 \m=+-\ 0 . 0 1 U/ml, n = 14; P < 0.001). Skeletal growth was determined with the tibia test and by a radiograph of each rat. The width of the proximal epiphyseal growth plate of the tibia was significantly increased in group C compared to group B (C: 204 \ m=+-\ 4.8 \g=m\m, n = 12 vs 181 \ m=+-\ 6.5 \g=m\m, n = 13; P < 0.005). On 
were divided into two groups. Group B received solvent solution and group C 1 mg/kg body weight per day of glibenclamide ip for the following 9 days. Group A consisted on non-operated normal rats. Twenty-four hours after the last injections and after a 12 h overnight fast the body weights of groups B and C were not different, the increase during the 10 days being 10% in both groups. Serum insulin (IRI) was significantly higher in group C than in group B (C: 8.0 \ m=+-\0.3 \g=m\U/ml, n = 14 vs B: 4.9 \m=+-\1.0 \g=m\U/ml,n = 14; P < 0.01, mean \m=+-\sem) as was serum somatomedin bioactivity (SM)-porcine cartilage assay\p=m-\(C: 1.06 \m=+-\ 0. 1U/ml, n = 14vsB:0.41 \m=+-\ 0 . 0 1 U/ml, n = 14; P < 0.001). Skeletal growth was determined with the tibia test and by a radiograph of each rat. The width of the proximal epiphyseal growth plate of the tibia was significantly increased in group C compared to group B (C: 204 \ m=+-\ 4.8 \g=m\m, n = 12 vs 181 \ m=+-\ 6.5 \g=m\m, n = 13; P < 0.005). On (Finney 1952 (Daughaday 1973 In the present experiments one normal and 2 hypophysectomized groups of rats were studied. Removal of the pituitary gland and subsequent solvent injections decreased the serum SM remark¬ ably, confirming previous reports (Kaufmann et al. 1978; Takano et al. 1978) , whereas treatment of the hypophysectomized animals with the sul¬ phonylurea drug glibenclamide returned the serum somatomedin concentration to the normal range.
For the rat the minimal effective iv dose of glibenclamide was 0.1 mg/kg body weight (Schmidt et al. 1969) . In the present study 10 times that dose was injected ip into the hypophysectomized rats. In rabbits the serum half-life of the drug was 7.4 h (Christ et al. 1969) (Heinze et al. 1981 ). Both growth hormone deficiency (Soman et al. 1978) (Heinze et al. 1981) .
